Recent days, FDA approved new drug for breast cancer, this breast cancer drug has
generic name kadcyla. Kadcyla working when a breast cancer patient in
the phase of metatesis. So its must be combined with another curing
methode such of chemoterapy. Kadcyla , based on clinical experience
capable to improve live quality of breast cancer patient. Because
kadcyla is very selective drug and only targeting cancer cell, so kadcyla has minor side effect.
No comments:
Post a Comment